CAS 157160-99-1

Benzoic acid, 4-chloro-3-nitro-, 1,1-dimethylethyl ester

Description:

Benzoic acid, 4-chloro-3-nitro-, 1,1-dimethylethyl ester, with the CAS number 157160-99-1, is an organic compound characterized by its ester functional group derived from benzoic acid. This compound features a benzoic acid backbone substituted with a chlorine atom at the para position and a nitro group at the meta position relative to the ester linkage. The presence of the 1,1-dimethylethyl group (tert-butyl) enhances its hydrophobic properties, making it less soluble in water but more soluble in organic solvents. This compound is typically used in various chemical syntheses and may exhibit biological activity, which can be of interest in pharmaceutical and agrochemical research. Its structural features suggest potential reactivity, particularly in electrophilic aromatic substitution reactions due to the electron-withdrawing nature of the nitro and chloro substituents. Safety and handling precautions should be observed, as with many organic compounds, due to potential toxicity and environmental impact.

Formula: C₁₁H₁₂ClNO₄

Benzoic acid, 4-chloro-3-nitro-, 1,1-dimethylethyl ester

CAS: 157160-99-1

Formula: C₁₁H₁₂ClNO₄

Purity: 95%

Color and Shape: Solid

Molecular weight: 257.6703

Ref: IN-DA001P9G

tert-Butyl 4-chloro-3-nitrobenzoate

CAS: 157160-99-1

tert-Butyl 4-chloro-3-nitrobenzoate

Purity: 95%

Molecular weight: 257.67g/mol

Ref: 54-OR1054299

Tert-butyl 4-chloro-3-nitrobenzoate

CAS: 157160-99-1

Purity: 95%

Molecular weight: 257.6700134

Ref: 10-F651484

tert-Butyl 4-chloro-3-nitrobenzoate

CAS: 157160-99-1

Tert-butyl 4-chloro-3-nitrobenzoate is a molecule inhibitor that binds to the active site of peroxidase. Tert-butyl 4-chloro-3-nitrobenzoate has been shown to have an anti-cancer effect on cancer cells by inhibiting the production of reactive oxygen species and reducing their proliferation. The drug also inhibits the activity of kinases, which are enzymes that regulate cell division. Tert-butyl 4-chloro-3-nitrobenzoate has been shown to be clinically effective for the treatment of myocardial infarction in rats.

Formula: C₁₁H₁₂ClNO₄

Purity: Min. 95%

Molecular weight: 257.67 g/mol

Ref: 3D-HGA16099